Ginseng and Ginsenoside Re Do Not Improve β-Cell Function or Insulin Sensitivity in Overweight and Obese Subjects With Impaired Glucose Tolerance or Diabetes
暂无分享,去创建一个
[1] S. Klein,et al. Reproducibility of glucose, fatty acid and VLDL kinetics and multi-organ insulin sensitivity in obese subjects with non-alcoholic fatty liver disease , 2011, International Journal of Obesity.
[2] E. Kang,et al. Korean red ginseng (Panax ginseng) improves insulin sensitivity and attenuates the development of diabetes in Otsuka Long-Evans Tokushima fatty rats. , 2009, Metabolism: clinical and experimental.
[3] Lars P Christensen,et al. Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. , 2009, Advances in food and nutrition research.
[4] Libin Zhou,et al. Ginsenoside Rb1 stimulates glucose uptake through insulin-like signaling pathway in 3T3-L1 adipocytes. , 2008, The Journal of endocrinology.
[5] C. Flexner,et al. Pharmacokinetic and metabolic effects of American ginseng (Panax quinquefolius) in healthy volunteers receiving the HIV protease inhibitor indinavir , 2008, BMC complementary and alternative medicine.
[6] G. Ning,et al. Ginsenoside Re reduces insulin resistance through inhibition of c-Jun NH2-terminal kinase and nuclear factor-kappaB. , 2008, Molecular endocrinology.
[7] Lawrence A Leiter,et al. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[8] H. Aung,et al. American ginseng berry juice intake reduces blood glucose and body weight in ob/ob mice. , 2007, Journal of food science.
[9] Yeong Shik Kim,et al. Simultaneous quantification of 14 ginsenosides in Panax ginseng C.A. Meyer (Korean red ginseng) by HPLC-ELSD and its application to quality control. , 2007, Journal of pharmaceutical and biomedical analysis.
[10] Guangji Wang,et al. Pharmacokinetic and absolute bioavailability study of total panax notoginsenoside, a typical multiple constituent traditional chinese medicine (TCM) in rats. , 2007, Biological & pharmaceutical bulletin.
[11] Lawrence A Leiter,et al. Korean Red Ginseng Rootlets Decrease Acute Postprandial Glycemia: Results from Sequential Preparation- and Dose-Finding Studies , 2006, Journal of the American College of Nutrition.
[12] D. Kennedy,et al. Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity , 2005, Journal of psychopharmacology.
[13] Lawrence A Leiter,et al. Null and Opposing Effects of Asian Ginseng (Panax ginseng C.A. Meyer) on Acute Glycemia: Results of Two Acute Dose Escalation Studies , 2003, Journal of the American College of Nutrition.
[14] Steve L. Taylor,et al. Advances in Food and Nutrition Research , 2003 .
[15] M. Schubert-Zsilavecz,et al. Degradation of ginsenosides in humans after oral administration. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[16] Claudio Cobelli,et al. The oral glucose minimal model: Estimation of insulin sensitivity from a meal test , 2002, IEEE Transactions on Biomedical Engineering.
[17] K. Polonsky,et al. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. , 2002, Diabetes.
[18] J. Horowitz,et al. Gender differences in lipid and glucose kinetics during short-term fasting. , 2001, American journal of physiology. Endocrinology and metabolism.
[19] Claudio Cobelli,et al. Oral Glucose Tolerance Test Minimal Model Indexes of β-Cell Function and Insulin Sensitivity , 2001 .
[20] Lawrence A Leiter,et al. Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes. , 2000, Diabetes care.
[21] V. Vuksan,et al. American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. , 2000, Archives of internal medicine.
[22] J. Olefsky,et al. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects. , 2000, Diabetes care.
[23] M. Matsuda,et al. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. , 1999, Diabetes care.
[24] A. Rautio,et al. Ginseng Therapy in Non-Insulin-Dependent Diabetic Patients: Effects on psychophysical performance, glucose homeostasis, serum lipids, serum aminoterminalpropeptide concentration, and body weight , 1995, Diabetes Care.
[25] L. Groop,et al. Effects of weight loss on substrate oxidation, energy expenditure, and insulin sensitivity in obese individuals. , 1992, The American journal of clinical nutrition.
[26] M. Kimura,et al. Effects of hypoglycemic components in ginseng radix on blood insulin level in alloxan diabetic mice and on insulin release from perfused rat pancreas. , 1981, Journal of pharmacobio-dynamics.